Bioactivity | EBOV-IN-7 (compound 26) is an inhibitor of the Ebola virus EBOV with an IC50 of 2.04 μM against EBOV-GP pseudotyped virus (pEBOV). EBOV-IN-7 has inhibitory effects on cancer cells and inhibits the EBOV-GPcl/NPC1 interaction.[8][1]. |
Target | Ebola virus |
Invitro | EBOV-IN-7 (compound 26) 对 HeLa 细胞的 CC50 为 60 μM,且对 Vero 细胞的细胞毒性低,CC50 >100 μM[1]。EBOV-IN-7 (50 μM) 显著干扰 EBOV-GPcl/NPC1 相互作用,对 EBOV-GP-假型病毒 (pEBOV) 的 IC50 为 2.04 μM[1]。EBOV-IN-7 对非洲猪瘟病毒 ASFV 的 IC50 为 15.75 μM[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> EBOV-IN-7 相关抗体: |
CAS | 68207-16-9 |
Formula | C18H19ClN4O3S |
Molar Mass | 406.89 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Lasala F, et al. Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses. Antiviral Res. 2021 Feb;186:105011. |